Dergi makalesi Açık Erişim
Topcu, Beril Tas; Kaplan, Ozan; Pehlivan, Sibel Bozdag; Celebier, Mustafa; Oner, Levent
{
"conceptrecid": "278014",
"created": "2025-04-17T16:55:14.514504+00:00",
"doi": "10.25135/jcm.2310.2937",
"files": [
{
"bucket": "c8d9a64b-a265-4b38-817d-3796da0cfdc7",
"checksum": "md5:2a16f3ca175209f8ba61f9b7c4e63913",
"key": "10-25135-jcm-2310-2937.pdf",
"links": {
"self": "https://aperta.ulakbim.gov.tr/api/files/c8d9a64b-a265-4b38-817d-3796da0cfdc7/10-25135-jcm-2310-2937.pdf"
},
"size": 520443,
"type": "pdf"
}
],
"id": 278015,
"links": {
"badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.25135/jcm.2310.2937.svg",
"bucket": "https://aperta.ulakbim.gov.tr/api/files/c8d9a64b-a265-4b38-817d-3796da0cfdc7",
"doi": "https://doi.org/10.25135/jcm.2310.2937",
"html": "https://aperta.ulakbim.gov.tr/record/278015",
"latest": "https://aperta.ulakbim.gov.tr/api/records/278015",
"latest_html": "https://aperta.ulakbim.gov.tr/record/278015"
},
"metadata": {
"access_right": "open",
"access_right_category": "success",
"communities": [
{
"id": "tubitak-destekli-proje-yayinlari"
}
],
"creators": [
{
"affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkiye",
"name": "Topcu, Beril Tas"
},
{
"affiliation": "Hacettepe Univ, Fac Pharm, Dept Analyt Chem, Ankara, Turkiye",
"name": "Kaplan, Ozan"
},
{
"affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkiye",
"name": "Pehlivan, Sibel Bozdag"
},
{
"affiliation": "Hacettepe Univ, Fac Pharm, Dept Analyt Chem, Ankara, Turkiye",
"name": "Celebier, Mustafa"
},
{
"affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkiye",
"name": "Oner, Levent"
}
],
"description": "<p>The use of poly (ADP -ribose) polymerase (PARP) inhibitors for cancer treatment has been reported previously. Talazoparib is a PARP inhibitor, and its solubility problems encouraged us to prepare talazoparib-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles for use in brain cancer models. To determine the encapsulation efficiency and release profile, a reversed -phase high-pressure liquid chromatography (RP-HPLC) method was developed and validated. A Shiseido 5 mu m C18 100 angstrom column (250 x 4.6 mm) was used with a flow rate of 1.0 mL/min. Isocratic elution was performed using an acetonitrile:phosphate buffer (100 mm, pH 6.25) (35:65 v/v) mixture. The injection volume was 5 mu L and UV detection was performed at 227 nm. The method was linear within the range from 0.1 to 12.5 mu g/mL. The encapsulation efficiency and release profile of the prepared formulation were analyzed using the developed RP-HPLC method, and it was found that the encapsulation efficiency was 65.17% +/- 0.50 and the release of the talazoparib was around 40% within 5 h and remained stable for 25 h. The RP-HPLC method developed in the present study can be adapted for further applications to determine talazoparib in its commercial formulations and proposed encapsulated drug delivery systems.</p>",
"doi": "10.25135/jcm.2310.2937",
"has_grant": false,
"journal": {
"issue": "1",
"pages": "9",
"title": "JOURNAL OF CHEMICAL METROLOGY",
"volume": "18"
},
"license": {
"id": "cc-by"
},
"publication_date": "2024-01-01",
"relations": {
"version": [
{
"count": 1,
"index": 0,
"is_last": true,
"last_child": {
"pid_type": "recid",
"pid_value": "278015"
},
"parent": {
"pid_type": "recid",
"pid_value": "278014"
}
}
]
},
"resource_type": {
"subtype": "article",
"title": "Dergi makalesi",
"type": "publication"
},
"science_branches": [
"Di\u011fer"
],
"title": "Development of an RP-HPLC method to evaluate the basic characteristics of talazoparib-loaded PLGA nanoparticles"
},
"owners": [
1
],
"revision": 1,
"stats": {
"downloads": 0.0,
"unique_downloads": 0.0,
"unique_views": 0.0,
"version_downloads": 0.0,
"version_unique_downloads": 0.0,
"version_unique_views": 0.0,
"version_views": 0.0,
"version_volume": 0.0,
"views": 0.0,
"volume": 0.0
},
"updated": "2025-04-17T16:55:14.555301+00:00"
}
| Görüntülenme | 0 |
| İndirme | 0 |
| Veri hacmi | 0 Bytes |
| Tekil görüntülenme | 0 |
| Tekil indirme | 0 |